Most of the agentic AI conversation in clinical research is aimed at the wrong target.
Can it run the study? Can it replace the monitor? Can it make the call?
Wrong questions. And chasing them is exactly why the pilots stall.
Here’s where agentic AI actually earns its keep in a trial right now — and it’s almost insultingly unglamorous.
Reconciliation. The tireless, mind-numbing cross-checking that humans do badly precisely because it’s mind-numbing.
Is every required document in the TMF, current version, signed, for every site? Is there a 1572 that quietly expired at site 23? A CV past its refresh? A consent version one revision behind in one place? Does the randomization system agree with the EDC agree with the drug accountability log?
None of that takes judgment. All of it takes patience no human reliably has at 5pm on the fortieth site file.
And here’s why it’s worth a fortune: those mismatches are exactly what an audit finds. What an inspector opens with. The boring discrepancy you missed is the finding that derails the visit.
So the most valuable agent in clinical research isn’t the one that decides anything. It’s the one that notices the missing signature before the inspector does.
It’s also the safest place to start. The human still owns every decision. The agent surfaces the discrepancy; a person acts on it. No autonomy to validate, no accountability gap to explain — just a tireless second set of eyes on the work nobody wants to do twice.
Stop trying to turn the agent into the scientist.
Turn it into the most patient coordinator’s assistant you’ve ever had. That’s the version that ships this year.